Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1947 1
1948 8
1949 9
1950 3
1951 6
1952 11
1953 7
1954 1
1955 1
1956 1
1958 2
1960 1
1961 2
1962 2
1963 2
1964 4
1965 5
1966 10
1967 3
1968 7
1969 9
1970 11
1971 17
1972 9
1973 7
1974 9
1975 10
1976 13
1977 7
1978 7
1979 13
1980 9
1981 8
1982 8
1983 12
1984 18
1985 21
1986 14
1987 12
1988 15
1989 26
1990 26
1991 41
1992 29
1993 29
1994 44
1995 55
1996 51
1997 33
1998 29
1999 33
2000 20
2001 29
2002 21
2003 27
2004 33
2005 37
2006 49
2007 57
2008 58
2009 46
2010 51
2011 51
2012 70
2013 58
2014 59
2015 44
2016 37
2017 43
2018 54
2019 38
2020 40
2021 48
2022 57
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,630 results
Results by year
Filters applied: . Clear all
Page 1
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
Marcus R, Davies A, Ando K, Klapper W, Opat S, Owen C, Phillips E, Sangha R, Schlag R, Seymour JF, Townsend W, Trněný M, Wenger M, Fingerle-Rowson G, Rufibach K, Moore T, Herold M, Hiddemann W. Marcus R, et al. N Engl J Med. 2017 Oct 5;377(14):1331-1344. doi: 10.1056/NEJMoa1614598. N Engl J Med. 2017. PMID: 28976863 Free article. Clinical Trial.
The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma.
Opat S, Tedeschi A, Linton K, McKay P, Hu B, Chan H, Jin J, Sobieraj-Teague M, Zinzani PL, Coleman M, Thieblemont C, Browett P, Ke X, Sun M, Marcus R, Portell CA, Ardeshna K, Bijou F, Walker P, Hawkes EA, Mapp S, Ho SJ, Talaulikar D, Zhou KS, Co M, Li X, Zhou W, Cappellini M, Tankersley C, Huang J, Trotman J. Opat S, et al. Among authors: marcus r. Clin Cancer Res. 2021 Dec 1;27(23):6323-6332. doi: 10.1158/1078-0432.CCR-21-1704. Epub 2021 Sep 15. Clin Cancer Res. 2021. PMID: 34526366 Free PMC article.
COVID-19: Implications for People with Chagas Disease.
Zaidel EJ, Forsyth CJ, Novick G, Marcus R, Ribeiro ALP, Pinazo MJ, Morillo CA, Echeverría LE, Shikanai-Yasuda MA, Buekens P, Perel P, Meymandi SK, Ralston K, Pinto F, Sosa-Estani S. Zaidel EJ, et al. Among authors: marcus r. Glob Heart. 2020 Oct 13;15(1):69. doi: 10.5334/gh.891. Glob Heart. 2020. PMID: 33150134 Free PMC article. Review.
Resistance strength training exercise in children with spinal muscular atrophy.
Lewelt A, Krosschell KJ, Stoddard GJ, Weng C, Xue M, Marcus RL, Gappmaier E, Viollet L, Johnson BA, White AT, Viazzo-Trussell D, Lopes P, Lane RH, Carey JC, Swoboda KJ. Lewelt A, et al. Among authors: marcus rl. Muscle Nerve. 2015 Oct;52(4):559-67. doi: 10.1002/mus.24568. Muscle Nerve. 2015. PMID: 25597614 Free PMC article.
Eccentric exercise in rehabilitation: safety, feasibility, and application.
LaStayo P, Marcus R, Dibble L, Frajacomo F, Lindstedt S. LaStayo P, et al. Among authors: marcus r. J Appl Physiol (1985). 2014 Jun 1;116(11):1426-34. doi: 10.1152/japplphysiol.00008.2013. Epub 2013 Jul 3. J Appl Physiol (1985). 2014. PMID: 23823152 Free article. Review.
Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.
Hiddemann W, Barbui AM, Canales MA, Cannell PK, Collins GP, Dürig J, Forstpointner R, Herold M, Hertzberg M, Klanova M, Radford J, Seymour JF, Tobinai K, Trotman J, Burciu A, Fingerle-Rowson G, Wolbers M, Nielsen T, Marcus RE. Hiddemann W, et al. Among authors: marcus re. J Clin Oncol. 2018 Aug 10;36(23):2395-2404. doi: 10.1200/JCO.2017.76.8960. Epub 2018 Jun 1. J Clin Oncol. 2018. PMID: 29856692 Clinical Trial.
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.
Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F, Macchioni P, Pipitone N, Amo MD, Espígol-Frigolé G, Cid MC, Martínez-Taboada VM, Nordborg E, Direskeneli H, Aydin SZ, Ahmed K, Hazleman B, Silverman B, Pease C, Wakefield RJ, Luqmani R, Abril A, Michet CJ, Marcus R, Gonter NJ, Maz M, Carter RE, Crowson CS, Matteson EL. Dasgupta B, et al. Among authors: marcus r. Ann Rheum Dis. 2012 Apr;71(4):484-92. doi: 10.1136/annrheumdis-2011-200329. Ann Rheum Dis. 2012. PMID: 22388996 Free PMC article.
The development and initial validation of the Russian version of the BASIS-24.
Madden LM, Farnum SO, Bromberg DJ, Barry DT, Mazhnaya A, Fomenko T, Meteliuk A, Marcus R, Rozanova J, Poklad I, Dvoriak S, Altice FL. Madden LM, et al. Among authors: marcus r. Addict Sci Clin Pract. 2022 Nov 26;17(1):65. doi: 10.1186/s13722-022-00343-0. Addict Sci Clin Pract. 2022. PMID: 36435811 Free PMC article. Review.
1,630 results